Construction and validation of a gastroesophageal reflux symptom scale;Construcción y validación de un instrumente de medición de síntomas de enfermedad por reflujo gastroesofágico. Informe preliminar

Revista Medica de Chile

Volumn 127, Issue 10, 1999, Pages 1213-1222

  Manterola D, Carlos ^a   Muñoz N, Sergio ^b   Grande P, Luis ^b   Riedemann G, Pablo ^b  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b NONE

Author keywords

Esophageal Motility Disorders; Gastroesophageal reflux; Gastroscopy

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; MIDDLE AGED; QUESTIONNAIRE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TIME;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0348142487     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. THE GALLUP ORGANIZATION. Gallup Survey on heartburn across America. Princeton, NJ: 1988, 24.
2. NEBEL OT, FORNES MF, CASTELL DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am J Dig Dis 1976; 21: 953-6.
3. TRIMBLE KC, DOUGLAS S, PRYDE A. Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux. Dig Dis Sci 1995; 40: 1098-104.
4. GALMICHE JP, BRULEY DV. Symptoms and disease severity in gastroesophageal reflux disease. Scand J Gastroenterol 1994; 29 (Suppl) 201: 62-8.
5. BRAGHETTO I, VELASCO M. Reflujo gastroesofágico patológico. Clínica y diagnóstico. En Braghetto I, Csendes A (Eds). Patología benigna del esófago. Santiago. Chile. Editorial Mediterráneo 1989; 63-8.
6. PONCE J, HINOJOSA J, GARRIGUES V. Sintomatología y complicaciones. En Vilardell F. Ed. Patología de la secreción gástrica I. Barcelona, Ediciones Doyma, 1991; 31-9.
7. SONTAG SJ, SCHNELL TG, MILLER TQ, KHANDEWAL S, O'CONELL S, CHEJFEC G ET AL. Prevalence of oesophagitis in asthmatics. Gut 1992; 33: 872-6.
8. SPECHLER SJ, GORDON DW, COHEN J, WILLIFORD WO, KROLL W. The effects of antireflux therapy on pulmonary function in patients with severe gastroesophageal reflux disease. Am J Gastroenterol 1995; 90: 915-8.
9. ROS E. Dolor torácico de origen esofágico. En Navarro S, Terés J, Pique JM, Bordas JM (Eds), Técnicas de exploración y diagnóstico en gastroenterología. Barcelona, Editorial Masson-Salvat, 1993; 217-24.
10. MANTEROLA C. Evaluación del dolor esofágico. Gastroenterología Latinoamericana 1997; 8: 18-25.
11. MCDOUGALL NI, JOHNSTON BT, KEE F, COLLINS JSA, MCFARLAND RJ, LOVE AHG. Natural history of reflux oesophagitis: A 10 years follow up of its effect on patient symptomatology and quality of life. Gut 1996; 38: 481-6.
12. MANTEROLA C, GARRIDO L, MUÑOZ N. Registro continuo de pH intraesofágico de 24 h en individuos sanos. Rev Méd Chile 1997; 125: 1313-8.
13. STREINER DL, NORMAN GR. Validity. In Streiner DL (Ed). Health measurement scales. A practical guide to their development and use. New York: Oxford University Press, 1995; 144-62.
14. STREINER DL, NORMAN GR. Reliability. In Streiner DL (Ed). Health measurement scales. A practical guide to their development and use. New York: Oxford University Press 1995: 104-27.
15. CSENDES A, VALENZUELA J, BECKER P, ARRAZTOA JA, MEDINA E. Prevalencia de síntomas esofágicos y gastrointestinales en adultos chilenos. Rev Méd Chile 1989; 117: 146-9.
16. MOLD JW, REED LE, DAVIS AB, ALLEN ML, DECKTOR DL, ROBINSON M. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 1991; 86: 965-70.
17. RUTH M, MANSSON Y, SANDBERG N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol 1991; 26: 73-81.
18. RAIHA IJ, IMPIVAARA O, SEPPALA M, SOURANDER LB. Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly. J Am Geriatr Soc 1992; 40: 1209-11.
19. KAY L, JORGENSEN T, JENSEN KH. Epidemiology of abdominal symptoms in a random population: prevalence, incidence and natural history. Eur J Epidemiol 1994; 10: 559-66.
20. BOHMER CJ, KLINKENBERG-KNOL EC, NIEZEN-DE BOER RC, MEUWISSEN SG. The prevalence of gastrooesophageal reflux disease based on non-specific symptoms in institutionalised, intellectually disabled individuals. Eur J Gastroenterol Hepatol 1997; 9: 187-90.
21. MANTEROLA C, PÉREZ O. Prevalencia de síntomas de reflujo gastroesofágico en una población de estudiantes universitarios. Rev Chil Cir 1998; 50: 513-7.
22. MANTEROLA C, LÓPEZ A, YÁÑEZ P, BURGOS L, DE ARETXABALA X, FONSECA L ET AL. Análisis de pHmetría intraesofágica en 40 pacientes con reflujo gastroesofágico. Rev Chil Cir 1995; 47: 240-6.
23. MANTEROLA C, FIERRO J. El laboratorio esofágico en el estudio de la patología esofágica benigna. Rev Méd Sur 1996; 18: 20-9.
24. STREINER DL, NORMAN GR. Devising the items. In Streiner DL (Ed). Health measurement scales. A practical guide to their development and use. New York: Oxford University Press, 1995; 15-27.
25. STREINER DL, NORMAN GR. Selecting the items. In Streiner DL (Ed). Health measurement scales. A practical guide to their development and use. New York: Oxford University Press, 1995; 54-68.
26. DE VELLIS RF. Reliability. In De Vellis RF (Ed.) Scale development. Theory and aplications. New York, Newbury: SAGE Publications, 1991; 24-42.
27. MUÑOZ SR, BANGDIWALA SI. Interpretation of Kappa and B Statistics Measures of Agreement. J App Stat 1997; 24: 105-11.